好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2023 Annual Meeting | Industry Therapeutic Update from AbbVie: Rethinking Migraine: Reviewing New Data For The Treatment And Prevention Of Migraine Attacks

Monday 04/24/23
06:00 PM - 09:00 PM EST Add To Calendar
This program will be presented in-person only
This program is not expected to be available in the meeting's On Demand product.
Industry Therapeutic Update
Peter J. McAllister, MD, FAAN
General Neurology, Headache, Pain
At AbbVie, our commitment to preserve the personhood of those living with neurological disorders is unwavering. Every challenge in this uncharted territory makes us more determined and drives us harder to discover and deliver solutions for patients, care partners and clinicians. AbbVie's Neuroscience portfolio consists of approved therapies and a robust pipeline in neurological disorders. Please join us to learn about an AbbVie treatment for Migraine Attacks.


Please note that no CME will be given by any accredited organization for attending. Additionally, Industry Therapeutic Updates program content and the views expressed herein are those of the presenting corporate entity and not of the AAN. These programs are not an official part of the 2023 AAN Annual Meeting education or scientific programs, nor are they endorsed by the AAN. The AAN cannot affirm claims pertaining to FDA off-label medication, research use of pre-FDA drugs, or other research information that might be discussed. Industry Therapeutic Updates are industry events.
No CME available
Event Timeline
06:00 PM - 09:00 PM EST Speaker Industry Therapeutic Update from AbbVie: Rethinking Migraine: Reviewing New Data For The Treatment And Prevention Of Migraine Attacks
Faculty Disclosures
Peter J. McAllister, MD, FAAN Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for lilly. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for abbvie. Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for lundbeck.